Bristol researchers take major step towards Alzheimer's gene therapy
September 28, 2026
September 28, 2026
BRISTOL, England, Sept. 28 -- The University of Bristol issued the following news release:
* * *
Bristol researchers take major step towards Alzheimer's gene therapy
*
Dr Kevin Kemp and his research team at the University have been able to convert the high-risk Alzheimer's gene, APOE4, into the lower-risk APOE3 gene.
By targeting these genes, the hope is that the therapy could prevent or slow Alzheimer's in people wh . . .
* * *
Bristol researchers take major step towards Alzheimer's gene therapy
*
Dr Kevin Kemp and his research team at the University have been able to convert the high-risk Alzheimer's gene, APOE4, into the lower-risk APOE3 gene.
By targeting these genes, the hope is that the therapy could prevent or slow Alzheimer's in people wh . . .
